Bio-Rad Laboratories Inc. (BIO)
NYSE: BIO
· Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT
Bio-Rad Laboratories Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.55B | 2.54B | 2.57B | 2.58B | 2.56B | 2.61B | 2.67B | 2.72B | 2.77B | 2.78B | 2.8B | 2.8B | 2.87B | 2.9B | 2.92B | 2.98B | 2.88B | 2.7B |
Cost of Revenue | 1.2B | 1.18B | 1.19B | 1.18B | 1.18B | 1.21B | 1.24B | 1.26B | 1.27B | 1.25B | 1.23B | 1.23B | 1.23B | 1.25B | 1.28B | 1.28B | 1.25B | 1.18B |
Gross Profit | 1.35B | 1.36B | 1.38B | 1.4B | 1.38B | 1.39B | 1.43B | 1.46B | 1.5B | 1.53B | 1.57B | 1.57B | 1.64B | 1.64B | 1.64B | 1.7B | 1.63B | 1.52B |
Operating Income | 226M | 247.99M | 276.3M | 315.76M | 342.24M | 330.37M | 340.27M | 361.15M | 363M | 393.6M | 475.11M | 463.42M | 527.43M | 531.99M | 489.43M | 557.69M | 510.49M | 437.45M |
Interest Income | 82.3M | 84.2M | 82M | 82.9M | 84.7M | 84.6M | 100.9M | 96.4M | 87.1M | 76.1M | 25.8M | 13.7M | 6.13M | 1.33M | 1.33M | 4.73M | 6.1M | 15.4M |
Pretax Income | 450.12M | -2.75B | -2.34B | -1.01B | -1.73B | -443.86M | -850.1M | -187.21M | -533.48M | -255.94M | -4.71B | -7.84B | -2.61B | -230.07M | 5.44B | 8.55B | 5.22B | 5.31B |
Net Income | 319.17M | -2.16B | -1.84B | -778.69M | -1.33B | -322.37M | -637.32M | -153.54M | -424.03M | -188.96M | -3.63B | -6.03B | -1.94B | -101.13M | 4.25B | 6.66B | 4.05B | 4.1B |
Selling & General & Admin | 818.34M | 809.36M | 811.04M | 812.94M | 813.7M | 825.4M | 840.47M | 846.8M | 856.65M | 857.56M | 829.6M | 841.52M | 846.62M | 851.32M | 879.57M | 874.58M | 856.59M | 832.43M |
Research & Development | 304.92M | 303.43M | 293.9M | 276.49M | 229.03M | 234.76M | 245.74M | 249.73M | 276.14M | 278.13M | 265.73M | 269.4M | 263.93M | 260.29M | 271.66M | 267.55M | 262.61M | 251.21M |
Other Expenses | -42K | -1.84M | -1.84M | -1.8M | -1.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -579K | -675K | -675K | -675K | 919K | 1.01M |
Operating Expenses | 1.12B | 1.11B | 1.1B | 1.09B | 1.04B | 1.06B | 1.09B | 1.1B | 1.13B | 1.14B | 1.1B | 1.11B | 1.11B | 1.11B | 1.15B | 1.14B | 1.12B | 1.08B |
Interest Expense | 48.96M | 48.62M | 48.9M | 49.08M | 49.3M | 49.38M | 49.44M | 48.76M | 48.03M | 46.4M | 38.11M | 26.8M | 15.13M | 4.78M | 1.13M | 5.46M | 11.19M | 16.57M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.46M | 25.46M | 25.46M |
Cost & Expenses | 2.33B | 2.29B | 2.29B | 2.27B | 2.22B | 2.27B | 2.33B | 2.36B | 2.41B | 2.39B | 2.33B | 2.34B | 2.34B | 2.36B | 2.43B | 2.42B | 2.37B | 2.26B |
Income Tax Expense | 130.95M | -586.05M | -498.29M | -226.5M | -404.1M | -121.48M | -212.78M | -27.92M | -103.7M | -61.22M | -1.08B | -1.81B | -667.3M | -128.95M | 1.19B | 1.9B | 1.17B | 1.21B |
Shares Outstanding (Basic) | 27.23M | 27.94M | 28M | 27.95M | 28.39M | 28.52M | 28.79M | 29.1M | 29.36M | 29.6M | 29.68M | 29.71M | 29.79M | 29.93M | 29.92M | 29.81M | 29.76M | 29.82M |
Shares Outstanding (Diluted) | 27.23M | 27.95M | 28M | 27.98M | 28.39M | 28.54M | 28.82M | 29.22M | 29.36M | 29.75M | 29.79M | 29.73M | 29.79M | 29.93M | 29.92M | 30.22M | 30.15M | 30.19M |
EPS (Basic) | 11.76 | -76.17 | -65 | -27.28 | -47 | -10.33 | -21.46 | -5.72 | -14.9 | -6.43 | -121.34 | -201.82 | -64.54 | -2.71 | 142.64 | 223.36 | 135.85 | 137.73 |
EPS (Diluted) | 11.73 | -76.2 | -65.04 | -27.33 | -47.03 | -10.36 | -21.49 | -5.85 | -15.01 | -6.54 | -121.43 | -201.8 | -66.32 | -4.88 | 140.07 | 220.47 | 134.15 | 135.98 |
EBITDA | 686.19M | -2.52B | -2.1B | -759.62M | -1.48B | -187.98M | -596.37M | 62.92M | -296.04M | -35.12M | -4.5B | -7.65B | -2.42B | -52.27M | 5.61B | 8.73B | 5.38B | 5.47B |
EBIT | 499.09M | -2.7B | -2.29B | -956.12M | -1.68B | -394.48M | -800.66M | -138.45M | -483.61M | -205.01M | -4.67B | -7.81B | -2.59B | -221.88M | 5.44B | 8.56B | 5.23B | 5.32B |
Depreciation & Amortization | 187.1M | 183.1M | 192.8M | 196.5M | 195.5M | 206.5M | 204.3M | 201.37M | 187.57M | 172.57M | 168.97M | 162.6M | 171.7M | 172.6M | 173.1M | 165.59M | 155.79M | 146.99M |